Literature DB >> 11150654

Peptides as regulators of the immune system: emphasis on somatostatin.

S Krantic1.   

Abstract

Study of the communication between nervous and immune systems culminated in the understanding that cytokines, formerly considered exclusively as immune system-derived peptides, are endogenous to the brain and display central actions. More recently, immune cells have been recognized as a peripheral source of "brain-specific" peptides with immunomodulatory actions. This article reviews studies concerning reciprocal effects of selected cytokines and neuropeptides in the nervous and immune systems, respectively. The functional equivalence of these two categories of communicators is discussed with reference to the example of the actions of neuropeptide somatostatin in the immune system.

Mesh:

Substances:

Year:  2000        PMID: 11150654     DOI: 10.1016/s0196-9781(00)00347-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  19 in total

Review 1.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

2.  Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

Authors:  Elena Gonzalez-Rey; Nieves Varela; Amir F Sheibanie; Alejo Chorny; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

Review 3.  Somatostatin receptor scintigraphy in thoracic diseases.

Authors:  P Ameri; F Gatto; M Arvigo; G Villa; E Resmini; F Minuto; G Murialdo; D Ferone
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

4.  Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.

Authors:  Alireza Mojtahedi; Abass Alavi; Sanjay Thamake; Reza Amerinia; David Ranganathan; Izabela Tworowska; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

5.  Histamine 3 receptor activation mediates inhibition of acid secretion during Helicobacter-induced gastritis.

Authors:  Yana Zavros; Nisreen Mesiwala; Meghna Waghray; Andrea Todisco; Arthur Shulkes; Juanita L Merchant
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

Review 6.  New roles of a neuropeptide cortistatin in the immune system and cancer.

Authors:  Min Li; Shaoyu Yan; William E Fisher; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

7.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

8.  Identification, characterization of selenoprotein W and its mRNA expression patterns in response to somatostatin 14, cysteamine hydrochloride, 17β-estradiol and a binary mixture of 17β-estradiol and cysteamine hydrochloride in topmouth culter (Erythroculter ilishaeformis).

Authors:  Haiyan Dong; Wenbo Chen; Chao Sun; Jianwei Sun; Yanlin Wang; Chao Xie; Qianwen Fu; Junjie Zhu; Jinyun Ye
Journal:  Fish Physiol Biochem       Date:  2016-08-09       Impact factor: 2.794

9.  Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.

Authors:  Sunil Bhandari; Neil Watson; Ervine Long; Steve Sharpe; Wenwen Zhong; Shang-Zhong Xu; Stephen L Atkin
Journal:  J Histochem Cytochem       Date:  2008-04-28       Impact factor: 2.479

10.  Expression of the somatostatin receptor subtype 4 in intact and inflamed pulmonary tissues.

Authors:  Zoltán Varecza; Krisztián Elekes; Terézia László; Anikó Perkecz; Erika Pintér; Zoltán Sándor; János Szolcsányi; Dániel Keszthelyi; Arpád Szabó; Katalin Sándor; Tamás F Molnár; Zalán Szántó; Judit E Pongrácz; Zsuzsanna Helyes
Journal:  J Histochem Cytochem       Date:  2009-08-17       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.